Skip to main content
Investors
Scibase.com
Open menu
At a Glance
Open link menu
At a Glance
Investment Case
Our Strategy
Market Overview
Results & Reports
Open link menu
Results & Reports
Calendar
Financial Data
The Share
Open link menu
The Share
Shareholders
Insider Transactions
Analysts
Prospectus Regarding Shares
Share Capital Development
Warrants
Governance
Open link menu
Governance
Management and Board of Directors
Annual General Meeting
Articles of Association
Auditor
Certified Advisor
Committees
ESG - sustainability
Releases
Open link menu
Releases
Subscription Service
EN
Current language English, click to switch language
SV
Switch to Svenska
Search
Search
Search
Search on a site
Please fill out this field
Back
Close menu
Search on a site
Please fill out this field
Close
Jan 27 2025
Recalculation of warrants of series TO 2 following rights issue
Jan 23 2025
Nevisense (EIS) included in updated German (S1) imaging guidelines.
Jan 14 2025
SciBase announces final outcome of directed issue and rights issue
Jan 13 2025
SciBase announces outcome of directed issue and preliminary outcome of rights issue
Jan 03 2025
The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot
Dec 27 2024
Today the subscription period in SciBase rights issue begins
Dec 20 2024
SciBase letter from the CEO
Dec 20 2024
SciBase publishes prospectus
Dec 13 2024
Bulletin from the extraordinary general meeting in SciBase Holding AB (publ)
Nov 13 2024
SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient
Pagination
First page
Previous page
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Last page
Subscribe to
Close popup
Left
Right
